Optimal use of recent technological advances in insulin delivery and glucose monitoring
remain limited by the impact of behaviour on self‐care. In recent years, there has been a …

New discoveries continue to be made regarding the genetic basis for many overgrowth
syndromes and the development of a much needed molecular classification system for …

Cardiovascular disease (CVD) is the leading cause of death in Type 1 Diabetes (T1D). The
molecular basis for atherosclerosis in T1D is heavily influenced by hyperglycaemia and its …

Staphylococcal scalded skin syndrome (SSSS) is a toxin-mediated exfoliating skin condition
predominated by desquamation and blistering. Neonatal outbreaks have already been …

Congenital hyperinsulinism (CHI) results from inappropriate excessive insulin secretion by
the beta cells in the pancreas. A wide clinical spectrum of disease exists and a genetic …

Background: Despite much discussion regarding the clinical relevance of glycemic variation
(GV), little discourse has addressed the properties of the data set from which it is derived …

Background and Objective Controversy exists regarding which individuals will benefit most
from commencement of diabetes technologies such as continuous subcutaneous insulin …

Diabetes mellitus (DM) is a global public health issue. Type 1 diabetes (T1D) is the
predominant diabetes type in children and always requires insulin therapy. The incidence …

Covid-19 has significantly impacted health service provision, resulting in thousands of
deaths world-wide. The Irish Covid-19 experience began on the 29 February, with …

Background Pregnancy in women with type 1 diabetes mellitus (T1DM) is associated with an
increased risk of congenital malformations, obstetric complications and neonatal morbidity …